Abstract
Current Drug Targets - Cardiovascular & Hematological Disorders
Title: Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
Volume: 5 Issue: 6
Author(s): Paul Schoenhagen and Steven E. Nissen
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Schoenhagen Paul and Nissen E. Steven, Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression, Current Drug Targets - Cardiovascular & Hematological Disorders 2005; 5 (6) . https://dx.doi.org/10.2174/156800605774962013
DOI https://dx.doi.org/10.2174/156800605774962013 |
Print ISSN 1568-0061 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0061 |
Related Articles
-
Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
Current Drug Targets Peroxisome Proliferator-Activated Receptors and the Control of Fatty Acid Oxidation in Cardiac Hypertrophy
Mini-Reviews in Medicinal Chemistry Pharmacophore Modeling Methods in Focused Library Selection – Applications in the Context of a New Classification Scheme
Combinatorial Chemistry & High Throughput Screening Lipid-based Self-Adjuvanting Vaccines
Current Drug Delivery Meet Our Editorial Board Member
Medicinal Chemistry Flavonoids Health Benefits and Their Molecular Mechanism
Mini-Reviews in Medicinal Chemistry Antiulcer and Antioxidant Activity of a Lectin from Mucuna pruriens Seeds on Ethanol- induced Gastropathy: Involvement of Alpha-2 Adrenoceptors and Prostaglandins
Current Pharmaceutical Design Insulin Resistance-Induced Hypertension and a Role of Perivascular CGRPergic Nerves
Current Protein & Peptide Science QSAR & Complex Network Study of the HMGR Inhibitors Structural Diversity
Current Drug Metabolism 24-Hour Blood Pressure Control – A Predictor for Clinical Outcomes
Current Hypertension Reviews Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Current Diabetes Reviews Subclinical Thyroid Dysfunction and Cardiovascular Outcomes among Prospective Cohort Studies
Endocrine, Metabolic & Immune Disorders - Drug Targets The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Adhatoda vasica Nees: Phytochemical and Pharmacological Profile
The Natural Products Journal Bioactive Components and Pharmacological Action of Wikstroemia indica (L.) C. A. Mey and Its Clinical Application
Current Pharmaceutical Biotechnology The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Homocysteine, Cardiovascular Inflammation, and Myocardial Remodeling
Cardiovascular & Hematological Disorders-Drug Targets Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
Current Cancer Drug Targets Interaction of Anthocyanins with Drug-metabolizing and Antioxidant Enzymes
Current Medicinal Chemistry Editorial [Hot Topic: Cardiovascular Diagnostic Testing: Use and Limits of Biochemical Markers (Executive Editors: Aurelio Leone and Stefano Taddei)]
Current Pharmaceutical Design